Author

Yen-Chun Huang

Tamkang UniversityORCID 0000-0003-0872-8664Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Assay:electronic health records· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Hung‐Hsiang LiouiD· 1 shared Kai‐Yuan HsiaoiD· 1 shared Ming-Hsien Tsai· 1 shared Mingchih CheniD· 1 shared Wei-Shan ChangiD· 1 shared Yu‐Wei FangiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Hung‐Hsiang LiouORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Pharmacology & ToxicologyMedical Science MonitorPeer-reviewedApr 18, 2025

Renal outcomes of combination therapy with sodium-glucose cotransporter 2 inhibitors plus renin-angiotensin system blockers in patients with type 2 diabetes mellitus: A population-based cohort study

Ming-Hsien Tsai, Mingchih Chen, Yen-Chun Huang…·Yu‐Wei Fang

This study evaluates the renal outcomes of combining SGLT2 inhibitors with RAS blockers versus RAS blockers and DPP4 inhibitors in type 2 diabetes patients, finding better renal outcomes with the SGLT2i combination.

DOI 10.12659/msm.947153

humanelectronic health records

𝕏 PostBluesky